Introduction
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Overview
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Therapeutics Development
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Therapeutics Assessment
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Companies Involved in Therapeutics Development
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Drug Profiles
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Dormant Projects
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Discontinued Products
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Ascendia Pharmaceuticals LLC, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by AstraZeneca Plc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Athera Biotechnologies AB, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Bayer AG, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Cadrock Pty Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Capricor Therapeutics Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by CardioVascular BioTherapeutics Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Chong Kun Dang Pharmaceutical Corp, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by CSL Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Cynata Therapeutics Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by DalCor Pharmaceuticals Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Gilead Sciences Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Hemostemix Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Human Stem Cells Institute, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Idorsia Pharmaceutical Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Kowa Co Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by LipimetiX Development Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Livzon Pharmaceutical Group Co Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by MedImmune LLC, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Orion Corp, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Proteon Therapeutics Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Resverlogix Corp, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Reven Pharmaceuticals Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Supernus Pharmaceuticals Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by The Medicines Company, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Verseon Corp, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by VESSL Therapeutics Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by ViroMed Co Ltd, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by Virtual Drug Development Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline by XyloCor Therapeutics Inc, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Dormant Projects, H1 2019
Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Discontinued Products, H1 2019

List of Figures
Number of Products under Development for Coronary Artery Disease (CAD) (Ischemic Heart Disease), H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Number of Products by Top 10 Targets, H1 2019
Number of Products by Stage and Top 10 Targets, H1 2019
Number of Products by Top 10 Mechanism of Actions, H1 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
Number of Products by Top 10 Routes of Administration, H1 2019
Number of Products by Stage and Top 10 Routes of Administration, H1 2019
Number of Products by Top 10 Molecule Types, H1 2019
Number of Products by Stage and Top 10 Molecule Types, H1 2019

Companies Mentioned
• Ascendia Pharmaceuticals LLC
• AstraZeneca Plc
• Athera Biotechnologies AB
• Bayer AG
• Cadrock Pty Ltd
• Capricor Therapeutics Inc
• CardioVascular BioTherapeutics Inc
• Chong Kun Dang Pharmaceutical Corp
• CSL Ltd
• Cynata Therapeutics Ltd
• DalCor Pharmaceuticals Inc
• Gilead Sciences Inc
• Hemostemix Inc
• Human Stem Cells Institute
• Idorsia Pharmaceutical Ltd
• Kowa Co Ltd
• LipimetiX Development Inc
• Livzon Pharmaceutical Group Co Ltd
• MedImmune LLC
• Orion Corp
• Proteon Therapeutics Inc
• Resverlogix Corp
• Reven Pharmaceuticals Inc
• Supernus Pharmaceuticals Inc
• The Medicines Company
• Verseon Corp
• VESSL Therapeutics Ltd
• ViroMed Co Ltd
• Virtual Drug Development Inc
• XyloCor Therapeutics Inc